BioVisioN receives research grant within BioChancePLUS program
BioVisioN AG announced the receipt of approval of a research grant within the German BioChancePLUS program. The German Federal Ministry of education and Research (BMBF) will fund the Project on "Functional Peptidomics" that aims at the characterisation of proteases and protease inhibitors with 560,000 EUR. In the project BioVisioN will apply its patent-protected Peptidomics® technologies to analyse substrates and products of proteases in vivo. The inhibition of proteases is an important mode of action of therapies in fields like diabetes and thrombosis.
By investigating the action of several protease inhibitors in animal models, BioVisioN will discover biomarkers for drug efficacy and possible side effects that can be used in early and advanced stages of drug development thus allowing early selection of the optimal drug candidate and the proper selection of patients responding to the drug, speeding up drug development and contributing to cost reduction.
Most read news
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.